Table 2 Identity of proteins in 2-DE gel with increased or decreased intensity after onset of cGVHD
Accession No. | Spot No. | MW (KDa) | p l | Identified protein | (VI)/× 105* | (VI) Fold change |
|---|---|---|---|---|---|---|
P00738 | 489 | 46 | 4.8 | haptoglobin-β | 53.4 | +4.2 |
|  | 513 | 46 | 5.1 | haptoglobin-β | 47.1 | +7.3 |
|  | 522 | 45 | 5.2 | haptoglobin-β | 22.4 | +6.5 |
|  | 528 | 45 | 5.4 | haptoglobin-β | 6.5 | +8.4 |
|  | 552 | 40 | 5.6 | haptoglobin-β | newly appeared |  |
|  | 661 | 21 | 5.6 | haptoglobin-α | 22.8 | +37.1 |
|  | 663 | 21 | 5.9 | haptoglobin-α | 12.3 | +32.0 |
|  | 664 | 21 | 5.3 | haptoglobin-α | 7.4 | +35.2 |
P06727 | 488 | 47 | 4.8 | apolipoprotein A-IV | 60.2 | +25.5 |
| Â | 489 | 46 | 4.8 | apolipoprotein A-IV | 53.4 | +4.2 |
| Â | 491 | 48 | 4.7 | apolipoprotein A-IV | 21.0 | +15.0 |
P01009 | 489 | 46 | 4.8 | α-1-antitrypsin | 53.4 | +4.2 |
|  | 513 | 46 | 5.1 | α-1-antitrypsin | 47.1 | +7.3 |
|  | 528 | 45 | 5.4 | α-1-antitrypsin | 16.5 | +8.4 |
P27169 | 488 | 47 | 4.8 | serum paraoxonase | 60.2 | +25.5 |
| Â | 491 | 48 | 4.7 | serum paraoxonase | 21.0 | +15.0 |
P25311 | 488 | 47 | 4.8 | Zn-α-2-glycoprotein | 50.2 | +25.5 |
|  | 491 | 48 | 4.7 | Zn-α-2-glycoprotein | 21.0 | +15.5 |
P04278 | 492 | 48 | 5.1 | sex hormone-binding globulin | 1.2 | -5.1 |
P10909 | 537 | 39 | 4.8 | clusterin precursor | 0.6 | -4.5 |
| Â | 547 | 38 | 4.9 | clusterin precursor | 0.5 | -4.9 |
| Â | 556 | 36 | 4.8 | clusterin precursor | absence | Â |
| Â | 726 | 13 | 5.6 | clusterin precursor | 0.1 | -4.5 |
P02735 | 726 | 13 | 5.6 | serum amyloid A protein precursor | 0.1 | -4.5 |
P02787 | 416 | 29 | 6.6 | serotransferrin | absence | Â |
P01023 | 556 | 36 | 4.8 | α-2-microglobulin | 0.2 | -7.5 |
P01028 | 526 | 31 | 6.6 | complement C4 | absence | Â |